Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Higgins

Showing results (791-800 of 837) with videos related to

Pageof 84
Sort By:
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
The American Journal of Gastroenterology|January 9, 2013
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial dataB Joseph Elmunzer, Peter D R Higgins, Sameer D Saini, et al.
Journal of Leukocyte Biology|August 21, 2012
Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokinesAlexander Basran, Maisha Jabeen, Lynne Bingle, et al.
The American Journal of Gastroenterology|May 7, 2019
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's DiseaseJing Wu, David M Lubman, Subra Kugathasan, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2023
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitisRemo Panaccione, Silvio Danese, Wen Zhou, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 3, 2021
The prediction of morbidity related to vaginal delivery in nulliparous women - A secondary analysis from the genesis multicenter trialKhadijah I Ismail, Naomi Burke, Gerard Burke, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 10, 2024
Genotype-by-environment interactions and local adaptation shape selection in the US National Chip Processing TrialHusain I Agha, Jeffrey B Endelman, Jessica Chitwood-Brown, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Cell|May 21, 2021
Charting human development using a multi-endodermal organ atlas and organoid modelsQianhui Yu, Umut Kilik, Emily M Holloway, et al.
Pageof 84

Showing results (791-800 of 837) with videos related to

Sort By:
Pageof 84
The American Journal of Pathology|February 15, 2015
Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosisThomas H Sisson, Iyabode O Ajayi, Natalya Subbotina, et al.
The American Journal of Gastroenterology|January 9, 2013
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial dataB Joseph Elmunzer, Peter D R Higgins, Sameer D Saini, et al.
Journal of Leukocyte Biology|August 21, 2012
Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokinesAlexander Basran, Maisha Jabeen, Lynne Bingle, et al.
The American Journal of Gastroenterology|May 7, 2019
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's DiseaseJing Wu, David M Lubman, Subra Kugathasan, et al.
Alimentary Pharmacology & Therapeutics|November 27, 2023
Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitisRemo Panaccione, Silvio Danese, Wen Zhou, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 3, 2021
The prediction of morbidity related to vaginal delivery in nulliparous women - A secondary analysis from the genesis multicenter trialKhadijah I Ismail, Naomi Burke, Gerard Burke, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|April 10, 2024
Genotype-by-environment interactions and local adaptation shape selection in the US National Chip Processing TrialHusain I Agha, Jeffrey B Endelman, Jessica Chitwood-Brown, et al.
The American Journal of Gastroenterology|December 6, 2012
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion processLaurent Peyrin-Biroulet, Vincent Billioud, Geert D'Haens, et al.
Cell|May 21, 2021
Charting human development using a multi-endodermal organ atlas and organoid modelsQianhui Yu, Umut Kilik, Emily M Holloway, et al.
Pageof 84